Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioMarin Pharmaceutical Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BMRN
Nasdaq
2834
https://www.biomarin.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical (NASDAQ:BMRN shareholders incur further losses as stock declines 4.9% this week, taking five-year losses to 14%
- May 11th, 2022 11:32 am
BioMarin Hires Pharmaceutical Industry Leaders in Marketing and Accounting to Fill Strategic Roles Supporting Company's Growth Plans
- May 5th, 2022 8:04 pm
BioMarin to Present Findings from Ongoing Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the World Federation of Hemophilia 2022 World Congress, May 8-11, 2022, Including Five Platform Presentations
- May 5th, 2022 12:29 pm
BioMarin to Participate in the BofA Securities 2022 Healthcare Conference, Thursday, May 12 at 8:40amPT/11:40amET
- May 4th, 2022 1:00 pm
Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates
- May 2nd, 2022 3:04 pm
ResMed (RMD) Q3 Earnings Miss Estimates, Margins Decline
- May 2nd, 2022 12:34 pm
Alnylam (ALNY) Misses on Q1 Earnings, Lowers '22 Revenue View
- Apr 29th, 2022 4:33 pm
BioMarin (BMRN) Q1 Earnings and Revenues Beat Estimates
- Apr 28th, 2022 6:35 pm
Alkermes (ALKS) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
- Apr 28th, 2022 4:30 pm
BioMarin Pharmaceutical (BMRN) Q1 Earnings and Revenues Surpass Estimates
- Apr 27th, 2022 9:25 pm
BioMarin Announces Record Revenues in First Quarter 2022
- Apr 27th, 2022 8:02 pm
Drug/Biotech Stocks' Apr 27 Q1 Earnings Roster: GSK, AMGN & More
- Apr 26th, 2022 3:44 pm
BioMarin to Host First Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, April 27, at 4:30pm ET
- Apr 13th, 2022 1:00 pm
Why Is BioMarin (BMRN) Up 4.6% Since Last Earnings Report?
- Mar 25th, 2022 3:30 pm
BioMarin Announces Publication in New England Journal of Medicine of One-Year Results from Phase 3 Pivotal Trial with Valoctocogene Roxaparvovec Gene Therapy in Adults with Severe Hemophilia A
- Mar 17th, 2022 12:31 pm
Sanofi's (SNY) Hemophilia A Candidate Meets Study Endpoints
- Mar 10th, 2022 3:26 pm
Why BioMarin Pharmaceutical Tumbled on Thursday
- Feb 24th, 2022 10:09 pm
BioMarin (BMRN) Q4 Earnings Top Estimates, Sales Fall Y/Y
- Feb 24th, 2022 3:50 pm
BioMarin Pharmaceutical (BMRN) Q4 Earnings and Revenues Top Estimates
- Feb 23rd, 2022 10:25 pm
BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates
- Feb 23rd, 2022 9:03 pm
Scroll